Erythema multiforme after the third dose of mRNA-1273.

Gimeno Castillo, Javier; Rosés Gibert, Pau; Romero Abrio, Cristina; Menéndez Parrón, Aida; Iglesias Martínez, Erika; Arrue Michelena, Itziar; García Río, Irene

Gimeno Castillo, Javier; Rosés Gibert, Pau; Romero Abrio, Cristina; Menéndez Parrón, Aida; Iglesias Martínez, Erika; Arrue Michelena, Itziar; García Río, Irene.

Gimeno Castillo J; Department of Dermatology, Hospital Universitario Araba, Vitoria, Spain.
Rosés Gibert P; Department of Dermatology, Hospital Universitario Araba, Vitoria, Spain.
Romero Abrio C; Department of Pathology, Hospital Universitario Araba, Vitoria, Spain.
Menéndez Parrón A; Department of Dermatology, Hospital Universitario Araba, Vitoria, Spain.
Iglesias Martínez E; Department of Pathology, Hospital Universitario Araba, Vitoria, Spain.
Arrue Michelena I; Department of Dermatology, Hospital Universitario Araba, Vitoria, Spain.
García Río I; Department of Dermatology, Hospital Universitario Araba, Vitoria, Spain.

Dermatol Ther ; 35(6): e15497, 2022 06.

Article in English | MEDLINE | ID: covidwho-1779222

Subject(s)

2019-nCoV Vaccine mRNA-1273; Erythema Multiforme; Erythema Multiforme/diagnosis; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Erythema Multiforme / 2019-nCoV Vaccine mRNA-1273 Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Dth.15497

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google